STEGLUJAN 15 mg/1

Steglujan 15 mg/1 combines ertugliflozin and sitagliptin for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Steglujan 15 mg/1 is used to help manage type 2 diabetes in adults. This combination medication works by improving insulin sensitivity and reducing glucose absorption. It is typically prescribed alongside diet and exercise to support overall blood sugar control.

Common effects of Steglujan 15 mg/1 may include urinary tract infections, hypoglycemia, and gastrointestinal discomfort. Individual responses can vary, and not everyone will experience these effects.

Handle Steglujan 15 mg/1 with care, especially if you have a history of kidney or liver issues. Always follow your healthcare provider's guidance regarding its use and monitor for any adverse reactions.

Steglujan 15 mg/1 may interact with certain medications, including insulin, other diabetes drugs, and diuretics. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.